BECTON DICKINSON & CO — Director's Dealing 2025

Dec 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2025-12-01

Reporting Person: Feld Michael (EVP, CRO & Pres. Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-01	Common Stock	S	75	$193.36	Disposed	16580	Direct